Exelixis, Inc. at its Annual Meeting of Shareholders of 2023, approved election to the Board of Directors of Farallon Capital Management, L.L.C. director candidate: Dave Johnson.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.24 USD | -0.52% | -3.29% | -15.34% |
05-20 | Exelixis Settles Cabometyx Patent Litigation with Cipla | MT |
05-14 | Transcript : Exelixis, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:35 PM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.34% | 5.92B | |
+9.94% | 115B | |
+10.52% | 105B | |
-12.02% | 22.71B | |
+4.34% | 21.83B | |
-10.77% | 18.18B | |
-41.92% | 16.52B | |
-15.66% | 16.01B | |
+1.65% | 14.14B | |
+18.22% | 10.71B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Exelixis, Inc. Elects Dave Johnson to its Board of Directors